X
Popular Searches
Hemato Oncology Cancer Treatment Rehabilitation Hospital Cancer Treatment for Children Car-T Treatment

REQUEST A CONSULTATION

Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.
x New Patient Current or Returning Refer a patient
search-icon
stethoscope
default doctor image

Dan Aderka

  • MD
Department:
  • Gastrointestinal Cancer Service
  • Gastrointestinal Cancer Department
Specialties:
  • Digestive System Oncology
Languages:
  • English
  • Hebrew
Request Consultation

About

Professor Dan Aderka is the head of the Gastrointestinal Cancer Service and chief specialist in the field of Digestive System Oncology.

Professor Aderka was involved in the planning and execution of clinical trials for the 1st, 2nd, and 3rd phases of the digestive system cancer treatment. In collaboration with the Weizmann Institute of Science professor Aderka carried out several academic research in the field of Tumor Necrosis Factor – TNF.

During his career professor Aderka has published more than 130 articles in various scientific journals.

He is the member of the Israeli Association of Clinical Oncology and Radiotherapy (ISCORT), the American Society of Oncology (ASCO) and the European Oncology Society (ESMO).

Positions

  • Head of the Gastrointestinal Cancer Service
  • Professor at the Sackler Medical School, Tel Aviv University, Israel

Education and Training

  • Graduated Sackler Medical School at Tel Aviv University

Board Certifications

  • Clinical oncology

Publications

A new look at the International Duration Evaluation of Adjuvant therapy (IDEA) classification-Defining novel predictive and prognostic markers in stage III colon cancer. Margalit O, Mamtani R, Yang YX, Reiss KA, Golan T, Halpern N, Aderka D, Giantonio B, Shacham-Shmueli E, Boursi B.

Assessing the prognostic value of carcinoembryonic antigen levels in stage I and II colon cancer. Margalit O, Mamtani R, Yang YX, Reiss KA, Golan T, Halpern N, Aderka D, Giantonio B, Shacham-Shmueli E, Boursi B.

Short- and Long-Term Survival in Metastatic Pancreatic Adenocarcinoma, 1993-2013.Golan T, Sella T, Margalit O, Amit U, Halpern N, Aderka D, Shacham-Shmueli E, Urban D, Lawrence YR.

All publications

Sheba Top 10 hospitals in the world
Sheba Knowledge Base

Request a consultation

Sheba Medical Center provides innovative, personalized medical care to patients from around the world. We are the largest, most comprehensive hospital in the Middle East and dedicated to providing advanced and compassionate medicine for everyone.

We welcome all cases, including the rarest and the most challenging. Our medical teams collaborate to provide the best possible health outcomes. From your initial inquiry through the long-term follow-up care, we are here for you.

Request a consultation and a Sheba Case Manager will contact you shortly:

New Patient Current & Returning Patients Refer a Patient